BIOMAT Database Logo BIOMAT Database Logo

Viral lower respiratory tract infections and preterm infants' healthcare utilisation. 2015

Simon B Drysdale, and Mireia Alcazar-Paris, and Theresa Wilson, and Melvyn Smith, and Mark Zuckerman, and Janet L Peacock, and Sebastian L Johnston, and Anne Greenough
Division of Asthma, Allergy and Lung Biology, MRC-Asthma UK Centre in Allergic Mechanisms of Asthma, King's College London, London, UK, simon.drysdale@kcl.ac.uk.

The aim of this study was to determine whether respiratory syncytial virus (RSV) and other viral lower respiratory tract infections (LRTI) in prematurely born infants were associated with similar effects on healthcare utilisation and related cost of care in the second compared to the first year after birth. Thirteen infants who had RSV LRTIs (RSV), 21 who had other viral LRTIs (other viral) and 25 had no viral LRTIs (no LRTI) were prospectively followed. Nasopharyngeal aspirates were collected whenever an infant had an LRTI regardless of whether it was in the hospital or in the community. Healthcare utilisation and the health-related cost of care were determined. Only the RSV group compared to the no LRTI group had higher overall respiratory costs in both year 1 (mean, £3,917 versus £24; p < 0.041) and year 2 (mean, £1,164 versus £61; p = 0.012). Only the RSV group required respiratory admissions; the RSV admission rate in year 2 was 3.4 % (number needed to treat 59). CONCLUSIONS RSV LRTIs are associated with increased healthcare utilisation and cost of care in the first and second year; nevertheless, if prophylaxis is to be cost-effective in the second year, a high risk group needs to be identified.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007234 Infant, Premature A human infant born before 37 weeks of GESTATION. Neonatal Prematurity,Premature Infants,Preterm Infants,Infant, Preterm,Infants, Premature,Infants, Preterm,Premature Infant,Prematurity, Neonatal,Preterm Infant
D010342 Patient Acceptance of Health Care Patients' willingness to receive health care. Acceptability of Health Care,Health Care Seeking Behavior,Acceptability of Healthcare,Acceptors of Health Care,Health Care Utilization,Nonacceptors of Health Care,Patient Acceptance of Healthcare,Care Acceptor, Health,Care Acceptors, Health,Care Nonacceptor, Health,Care Nonacceptors, Health,Health Care Acceptability,Health Care Acceptor,Health Care Acceptors,Health Care Nonacceptor,Health Care Nonacceptors,Healthcare Acceptabilities,Healthcare Acceptability,Healthcare Patient Acceptance,Healthcare Patient Acceptances,Utilization, Health Care
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D003362 Cost-Benefit Analysis A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. In contrast a cost effectiveness in general compares cost with qualitative outcomes. Cost and Benefit,Cost-Benefit Data,Benefits and Costs,Cost Benefit,Cost Benefit Analysis,Cost-Utility Analysis,Costs and Benefits,Economic Evaluation,Marginal Analysis,Analyses, Cost Benefit,Analysis, Cost Benefit,Analysis, Cost-Benefit,Analysis, Cost-Utility,Analysis, Marginal,Benefit and Cost,Cost Benefit Analyses,Cost Benefit Data,Cost Utility Analysis,Cost-Benefit Analyses,Cost-Utility Analyses,Data, Cost-Benefit,Economic Evaluations,Evaluation, Economic,Marginal Analyses
D003695 Delivery of Health Care The concept concerned with all aspects of providing and distributing health services to a patient population. Delivery of Dental Care,Health Care,Health Care Delivery,Health Care Systems,Community-Based Distribution,Contraceptive Distribution,Delivery of Healthcare,Dental Care Delivery,Distribution, Non-Clinical,Distribution, Nonclinical,Distributional Activities,Healthcare,Healthcare Delivery,Healthcare Systems,Non-Clinical Distribution,Nonclinical Distribution,Activities, Distributional,Activity, Distributional,Care, Health,Community Based Distribution,Community-Based Distributions,Contraceptive Distributions,Deliveries, Healthcare,Delivery, Dental Care,Delivery, Health Care,Delivery, Healthcare,Distribution, Community-Based,Distribution, Contraceptive,Distribution, Non Clinical,Distributional Activity,Distributions, Community-Based,Distributions, Contraceptive,Distributions, Non-Clinical,Distributions, Nonclinical,Health Care System,Healthcare Deliveries,Healthcare System,Non Clinical Distribution,Non-Clinical Distributions,Nonclinical Distributions,System, Health Care,System, Healthcare,Systems, Health Care,Systems, Healthcare
D006760 Hospitalization The confinement of a patient in a hospital. Hospitalizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069455 Palivizumab A humanized monoclonal antibody and ANTIVIRAL AGENT that is used to prevent RESPIRATORY SYNCYTIAL VIRUS INFECTIONS in high risk pediatric patients. MEDI 493,MEDI-493,Monoclonal Antibody MEDI-493,Synagis,MEDI493,Monoclonal Antibody MEDI 493,Monoclonal Antibody MEDI493

Related Publications

Simon B Drysdale, and Mireia Alcazar-Paris, and Theresa Wilson, and Melvyn Smith, and Mark Zuckerman, and Janet L Peacock, and Sebastian L Johnston, and Anne Greenough
Lung function in prematurely born infants after viral lower respiratory tract infections.
November 2007, The Pediatric infectious disease journal,
Simon B Drysdale, and Mireia Alcazar-Paris, and Theresa Wilson, and Melvyn Smith, and Mark Zuckerman, and Janet L Peacock, and Sebastian L Johnston, and Anne Greenough
Viral infections of the lower respiratory tract.
June 2012, Current infectious disease reports,
Simon B Drysdale, and Mireia Alcazar-Paris, and Theresa Wilson, and Melvyn Smith, and Mark Zuckerman, and Janet L Peacock, and Sebastian L Johnston, and Anne Greenough
Viral lower respiratory tract infections in Filipino children.
February 1990, The Journal of infectious diseases,
Simon B Drysdale, and Mireia Alcazar-Paris, and Theresa Wilson, and Melvyn Smith, and Mark Zuckerman, and Janet L Peacock, and Sebastian L Johnston, and Anne Greenough
Management of lower respiratory tract infections in infants.
April 1979, The New Zealand medical journal,
Simon B Drysdale, and Mireia Alcazar-Paris, and Theresa Wilson, and Melvyn Smith, and Mark Zuckerman, and Janet L Peacock, and Sebastian L Johnston, and Anne Greenough
Viral Respiratory Infections in Preterm Infants during and after Hospitalization.
March 2017, The Journal of pediatrics,
Simon B Drysdale, and Mireia Alcazar-Paris, and Theresa Wilson, and Melvyn Smith, and Mark Zuckerman, and Janet L Peacock, and Sebastian L Johnston, and Anne Greenough
Overnutrition, Nasopharyngeal Pathogenic Bacteria and Proinflammatory Cytokines in Infants with Viral Lower Respiratory Tract Infections.
July 2022, International journal of environmental research and public health,
Simon B Drysdale, and Mireia Alcazar-Paris, and Theresa Wilson, and Melvyn Smith, and Mark Zuckerman, and Janet L Peacock, and Sebastian L Johnston, and Anne Greenough
Viral lower respiratory tract infection in infants and young children.
July 2003, BMJ (Clinical research ed.),
Simon B Drysdale, and Mireia Alcazar-Paris, and Theresa Wilson, and Melvyn Smith, and Mark Zuckerman, and Janet L Peacock, and Sebastian L Johnston, and Anne Greenough
[Sequelae of viral lower respiratory tract infections in children].
November 2007, La Revue du praticien,
Simon B Drysdale, and Mireia Alcazar-Paris, and Theresa Wilson, and Melvyn Smith, and Mark Zuckerman, and Janet L Peacock, and Sebastian L Johnston, and Anne Greenough
Lower respiratory tract viral infections in hospitalized adult patients.
October 2009, Minerva medica,
Simon B Drysdale, and Mireia Alcazar-Paris, and Theresa Wilson, and Melvyn Smith, and Mark Zuckerman, and Janet L Peacock, and Sebastian L Johnston, and Anne Greenough
[Viral participation in acute lower respiratory infections in infants].
January 1988, Revista chilena de pediatria,
Copied contents to your clipboard!